Skip to main content

Scilex Holding Co

SCLX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001820190

No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q2 2026, worth $5.48M in total; no superinvestor holds it.

Other share classesSCLXW

Q1 2026 vs. Q4 2025

How the institutions holding Scilex Holding Co changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of SCLX: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders82573−4
Shares1.12M295.0K871.8K+47.0K (+5.7%)
Value$13.7M$3.60M$5.81M−$4.26M (−42.3%)

5 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Scilex Holding Co at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to SCLX in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC264,050$1.76M0.00%
Vanguard Fiduciary Trust Co39,658$264.1K0.00%
Vanguard Global Advisers, LLC2,937$19.6K0.00%
IFP Advisors, Inc576$3.84K0.00%
S&T Bank78$5190.00%
Advisory Services Network, LLC1$70.00%
Monetary Solutions, Ltd1$70.00%

Sold out (11)

Institutions that held Scilex Holding Co at the end of Q4 2025 and filed for Q1 2026 without it.

Not filed for Q1 2026 yet (5)

Institutions that held Scilex Holding Co at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SCLX in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc295,024$3.60M
Global Retirement Partners, LLC5$61
CIBC Private Wealth Group, LLC4$49
GPS Wealth Strategies Group, LLC4$49
Stephens Consulting, LLC2$25